drugset / Trial / NCT02623816
Symptom Control Satisfaction With Proton Pump Inhibitor Regimen
RandomizedParallel-groupOpen-labelTreatment
Summary
The overall aim of this study is to assess if patients with persistent gastroesophageal reflux disease (GERD) symptoms receiving sub-optimal omeprazole dosing experience improvement in GERD symptoms when prescribed an optimal dosing regimen. The optimal dosing regimen is defined as taking omeprazole 30 minutes prior to the first meal of the day.
Timeline
- Start
- 2014-08
- Primary completion
- 2015-12
- Completion
- 2015-12
Outcome
Met primary endpoint
paper GSAS symptom, frequency, and severity scores were significantly better when dosing was optimized for overall and heartburn-specific symptoms (P < 0.01 for all parameters). PMID 30094626 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omeprazole | Other / unclassified | 20 mg | — |